Want to join the conversation?
$AMRI and Icagen announced they have signed a 3-year collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients. $AMRI clients and customers gain access to Icagen's broad portfolio of assay tools and technologies for ion channel and transporter research.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.